PL3906012T3 - Utlenione pochodne fragmentów GDF-11 - Google Patents
Utlenione pochodne fragmentów GDF-11Info
- Publication number
- PL3906012T3 PL3906012T3 PL19702501.8T PL19702501T PL3906012T3 PL 3906012 T3 PL3906012 T3 PL 3906012T3 PL 19702501 T PL19702501 T PL 19702501T PL 3906012 T3 PL3906012 T3 PL 3906012T3
- Authority
- PL
- Poland
- Prior art keywords
- gdf
- fragments
- oxidized derivatives
- oxidized
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2019/012325 WO2020142103A1 (en) | 2019-01-04 | 2019-01-04 | Oxidized derivatives of gdf-11 fragments |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3906012T3 true PL3906012T3 (pl) | 2023-04-17 |
Family
ID=65244619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL19702501.8T PL3906012T3 (pl) | 2019-01-04 | 2019-01-04 | Utlenione pochodne fragmentów GDF-11 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210338557A1 (pl) |
EP (1) | EP3906012B1 (pl) |
CN (1) | CN113286576B (pl) |
BR (1) | BR112021013164B1 (pl) |
ES (1) | ES2930730T3 (pl) |
MX (1) | MX2021008115A (pl) |
PL (1) | PL3906012T3 (pl) |
PT (1) | PT3906012T (pl) |
TW (1) | TW202042784A (pl) |
WO (1) | WO2020142103A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112023023285A2 (pt) * | 2021-05-10 | 2024-01-23 | Dsm Ip Assets Bv | Purificação de tripeptídeo específico por acidificação |
CN117321068A (zh) * | 2021-05-10 | 2023-12-29 | 帝斯曼知识产权资产管理有限公司 | 通过使用醚纯化特定三肽 |
WO2024128080A1 (ja) * | 2022-12-16 | 2024-06-20 | 東亞合成株式会社 | 合成ペプチド及び構築物 |
KR20240133853A (ko) * | 2023-02-28 | 2024-09-05 | 루다큐어 주식회사 | 신규 펩타이드 및 이의 용도 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
US5962292A (en) * | 1993-09-07 | 1999-10-05 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing cis-3-hydroxy-L-proline |
RU2206573C1 (ru) * | 2001-12-27 | 2003-06-20 | Институт молекулярной генетики РАН | Семейство пептидов, обладающих нейротропными свойствами |
TWI415628B (zh) | 2006-02-28 | 2013-11-21 | Avon Prod Inc | 包含具有非天然胺基酸之胜肽之組合物及其使用方法 |
EP2382231A2 (en) * | 2009-01-16 | 2011-11-02 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
FR2941231B1 (fr) * | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
AU2010236730B2 (en) * | 2009-04-13 | 2012-09-20 | Elc Management Llc | Methionine sulfoxide peptide, compositions and methods of use |
EP2649984A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
CA2972015A1 (en) | 2014-12-23 | 2016-06-30 | Avon Products, Inc. | Peptides and their use in the treatment of skin |
US9597274B2 (en) * | 2015-06-17 | 2017-03-21 | Avon Products, Inc. | Peptides and their use in the treatment of skin |
-
2019
- 2019-01-04 PT PT197025018T patent/PT3906012T/pt unknown
- 2019-01-04 WO PCT/US2019/012325 patent/WO2020142103A1/en unknown
- 2019-01-04 BR BR112021013164-7A patent/BR112021013164B1/pt active IP Right Grant
- 2019-01-04 US US17/294,532 patent/US20210338557A1/en active Pending
- 2019-01-04 EP EP19702501.8A patent/EP3906012B1/en active Active
- 2019-01-04 ES ES19702501T patent/ES2930730T3/es active Active
- 2019-01-04 MX MX2021008115A patent/MX2021008115A/es unknown
- 2019-01-04 CN CN201980085356.0A patent/CN113286576B/zh active Active
- 2019-01-04 PL PL19702501.8T patent/PL3906012T3/pl unknown
- 2019-12-30 TW TW108148316A patent/TW202042784A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3906012A1 (en) | 2021-11-10 |
BR112021013164A2 (pt) | 2021-10-19 |
WO2020142103A1 (en) | 2020-07-09 |
ES2930730T3 (es) | 2022-12-21 |
CN113286576A (zh) | 2021-08-20 |
US20210338557A1 (en) | 2021-11-04 |
EP3906012B1 (en) | 2022-08-24 |
BR112021013164B1 (pt) | 2023-10-17 |
PT3906012T (pt) | 2022-11-28 |
MX2021008115A (es) | 2021-08-11 |
CN113286576B (zh) | 2024-05-14 |
TW202042784A (zh) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3349751A4 (en) | CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS | |
IL286218A (en) | Solid state forms of ripretinib | |
PL3906012T3 (pl) | Utlenione pochodne fragmentów GDF-11 | |
EP3937964A4 (en) | TREATMENT OF ONCOGENE-DRIVEN CANCERS | |
IL276592A (en) | History of Subtirum | |
IL292657A (en) | Therapeutic history of interleukin-22 | |
IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
EP3654987A4 (en) | USE OF AMINOALKYLBENZOTHIACEPINE DERIVATIVES | |
IL279497A (en) | Treatment of protein in the urine | |
EP3897649A4 (en) | COMBINED TREATMENT OF SOLID CANCERS | |
IL290815A (en) | History of alpha-d-galactopyranoside | |
IL286434A (en) | Nicoandyl derivatives | |
EP3565530A4 (en) | TREATMENT OF LATIVAL CANCER | |
IL310777A (en) | The history of S-alanine is altered | |
ZA202105399B (en) | Use of spiropidion | |
EP4026548A4 (en) | USE OF 5-METHYLTETRAHYDROFOLATE | |
EP3762428A4 (en) | COMBINATION TREATMENT OF CHEMORESE RESISTANT CANCER | |
CA209640S (en) | Safe | |
EP3979789A4 (en) | TREATMENT OF SAPROLEGNIA | |
EP4034125A4 (en) | TREATMENT OF DISEASES RELATED TO EXCITOTOXICITY | |
EP4065573A4 (en) | TREATMENT METHODS | |
EP4025218A4 (en) | TREATMENT PROCESSES | |
AU2019903588A0 (en) | Treatment of excitotoxicity-related conditions | |
GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
AU2019903451A0 (en) | Methods of treatment |